BRCA1 and BRCA2 proteins: Roles in health and disease

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 5, 1998, Pages 237-247

  Duncan, J A ^a   Reeves, J R ^a   Cooke, T G ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CHROMOSOME 13Q; CHROMOSOME MAP; EMBRYO DEVELOPMENT; FEMALE; GENE MUTATION; GENE SEQUENCE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; TISSUE DISTRIBUTION;

EID: 0031784624     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.5.237     Document Type: Review

References (85)

1. Abel KJ, Xu JZ, Yin GY, et al. Brca1 localization, sequence-analysis and identification of evolutionarily conserved domains. Hum Mol Genet 1995;4:2265-73.
2. Sharan SK, Bradley A, Murine Brca2: sequence, map position, and expression pattern. Genomics 1997;40:234-41.
3. Connor F, Smith A, Wooster R, et al. Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. Hum Mol Genet 1997;6:291-300.
4. Miki Y, Swensen J, Shattuckeidens D, et al. A strong candidate for the breast and ovarian-cancer susceptibility gene BRCA1. Science 1994;266:66-71.
5. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast-cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.
6. Tavtigian SV, Simard J, Rommens J, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996;12:333-7.
7. Lane TF, Deng CX, Elson A, et al. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 1995; 9:2712-22.
8. Thakur S, Zhang HB, Peng Y, et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol 1997;17:444-52.
9. Chen CF, Li S, Chen YM, et al. The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J Biol Chem 1996;271:32863-8.
10. Ludwig T, Chapman DL, Papaioannou VE, et al. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 1997;11:1226-41.
11. Callebaut I, Mornon JP. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett 1997;400:25-30.
12. Jensen Ra, Thompson Me, Jetton Tl, et al. BRCA1 protein products antibody specificity . . . functional motifs . . . and secreted tumor suppressors reply. Nat Genet 1996;13: 269-72.
13. 1 checkpoint control in the yeast saccharomyces-cerevisiae following exposure to DNA-damaging agents. Genetics 1994;138:271-81.
14. Weinert TA, Hartwell LH. The Rad9 gene controls the cell-cycle response to DNA damage in saccharomyces-cerevisiae. Science 1988;241:317-22.
15. Koonin EV, Altschul SF, Bork P. Functional motifs. Nat Genet 1996;13:266-8.
16. Wu LJC, Wang ZW, Tsan JT, et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 1996;14:430-40.
17. Jensen RA, Thompson ME, Jetton TL, et al. BRCA1 is secreted and exhibits properties of a granin. Nat Genet 1996;12:303-8.
18. Bradley A, Sharan SK. Brca1 protein products secreted tumor suppressors. Nat Genet 1996;13:268-9.
19. Wilson CA, Payton MN, Elliott GS, et al. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-A11b. Oncogene 1997;14:1-16.
20. Wang HC, Shao NS, Ding QM, et al. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 1997;15:143-57.
21. Bignell G, Micklem G, Stratton MR, et al. The BRC repeats are conserved in mammalian BRCA2 proteins. Hum Mol Genet 1997;6:53-8.
22. Milner J, Ponder B, Hughes Davies L, et al. Transcriptional activation functions in BRCA2. Nature 1997;386:772-3.
23. Sharan SK, Morimatsu M, Albrecht U, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 1997;386:804-10.
24. Mazoyer S, Dunning AM, Serova O, et al. A polymorphic stop codon m BRCA2. Nat Genet 1996;14:253-4.
25. Rajan JV, Marquis ST, Gardner HP, et al. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol 1997;184:385-401.
26. Zabludoff SD, Wright WW, Harshman K, et al. BRCA1 messenger-RNA is expressed highly during meiosis and spermiogenesis but not during mitosis of male germ-cells. Oncogene 1996;13:649-53.
27. Marquis ST, Rajan JV, Wynshawboris A, et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 1995;11:17-26.
28. Thomas JE, Smith M, Rubinfeld B, et al. Subcellular-localization and analysis of apparent 180-kda and 220-kda proteins of the breast-cancer susceptibility gene, BRCA1. J Biol Chem 1996;271:28630-5.
29. BernardGallon DJ, Crespin NC, Maurizis JC, et al. Cross-reaction between antibodies raised against the last 20 C-terminal amino acids of BRCA 1 (C-20) and human EGF and EGF-R in MCF 10a human mammary epithelial cell line. Int J Cancer 1997;71:123-6.
30. Scully R, Ganesan S, Brown M, et al. Location of BRCA1 in human breast and ovarian-cancer cells. Science 1996;272: 123-5.
31. Chen Y, Chen CF, Riley DJ, et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 1995;270: 789-91.
32. Holt JT, Thompson ME, Szabo C, et al. Growth-retardation and tumor-inhibition by BRCA1. Nat Genet 1996;12:298-302.
33. Coene E, Van Oostveldt P, Willems K, et al. BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus. Nat Genet 1997;16:122-4.
34. Bertwistle D, Swift S, Marston NJ, et al. Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res 1997;57:5485-8.
35. Chen Y, Farmer AA, Chen CF, et al. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 1996; 56:3168-72.
36. Scully R, Chen JJ, Plug A, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997;88:265-75.
37. Tashiro S, Kotomura N, Shinohara A, et al. S-phase specific formation of the human Rad51 protein nuclear foci in lymphocytes. Oncogene 1996;12:2165-70.
38. Scully R, Chen JJ, Ochs RL, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997;90:425-35.
39. Jin Y, Xu XL, Yang MCW, et al. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci USA 1997;94:12075-80.
40. 1 cyclin-dependent kinases. Genes Dev 1995;9:1149-63.
41. Chapman MS, Verma IM. Transcriptional activation by BRCA1. Nature 1996;382:678-9.
42. Somasundaram K, Zhang HB, Zeng YX, et al. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21 (waf1/cip1). Nature 1997;389:187-90.
43. Hakem R, delaPompa JL, Sirard C, et al. The tumor-suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 1996;85:1009-23.
44. Connor F, Bertwistle D, Mee PJ, et al. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat Genet 1997;17:423-30.
45. Zhang HT, Zhang X, Zhao HZ, et al. Relationship of p215(BRCA1) to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 1997;14:2863-9.
46. Thomas JE, Smith M, Tonkinson JL, et al. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ 1997;8:801-9.
47. Spillman MA, Bowcock AM. BRCA1 and BRCA2 messenger-RNA levels are coordinately elevated in human breast-cancer cells in response to estrogen. Oncogene 1996; 13:1639-45.
48. Gudas JM, Li T, Nguyen H, et al. Cell-cycle regulation of BRCA1 messenger-RNA in human breast epithelial-cells. Cell Growth Differ 1996;7:717-23.
49. Vaughn JP, Davis PL, Jarboe MD, et al. BRCA1 expression is induced before DNA-synthesis in both normal and tumor-derived breast cells. Cell Growth Differ 1996;7:711-5.
50. Rajan JV, Wang M, Marquis ST, et al. BRCA2 is coordinately regulated with BRCA1 during proliferation and differentiation in mammary epithelial-cells. Proc Natl Acad Sci USA 1996;93:13078-83.
51. Ruffner H, Verma IM. BRCA1 is a cell cycle-regulated nuclear phosphoprotem. Proc Natl Acad Sci USA 1997;94: 7138-43.
52. Aprelikova O, Kuthiala A, Bessho M, et al. BRCA1 protein level is not affected by peptide growth-factors in MCF10a cell-line. Oncogene 1996;13:2487-91.
53. Vaughn JP, Cirisano FD, Huper G, et al. Cell-cycle control of BRCA2. Cancer Res 1996;56:4590-4.
54. Wang SC, Lin SH, Su LK, et al. Changes in BRCA2 expression during progression of the cell cycle. Biochem Biophys Res Commun 1997;234:247-51.
55. Gudas JM, Nguyen H, Li T, et al. Hormone-dependent regulation of BRCA1 in human breast-cancer cells. Cancer Res 1995;55:4561-5.
56. Marks JR, Huper G, Vaughn JP, et al. BRCA1 expression is not directly responsive to estrogen. Oncogene 1997;14:115-21.
57. Norris J, Fan DJ, Aleman C, et al. Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 1995;270:22777-82.
58. Johannsson OT, Idvall I, Anderson C, et al. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 1997;33:362-71.
59. Marcus JN, Page DL, Watson P, et al. BRCA1 and BRCA2 hereditary breast carcinoma phenotypes. Cancer 1997;80: 543-56.
60. Lakhani SR, Easton DF, Stratton MR, et al. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997;349:1505-10.
61. Marcus JN, Watson P, Page DL, et al. BRCA2 and BRCA1 breast cancer phenotypes. Lab Invest 1997;76:110
62. Karp SE, Tonin PN, Begin LR, et al. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer 1997;80:435-41.
63. Beckmann MW, Picard F, An HX, et al. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast-cancer. Br J Cancer 1996;73: 1220-6.
64. Marcus JN, Watson P, Page DL, et al. Hereditary breast-cancer - pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 1996;77:697-709.
65. Eisinger F, Stoppalyonnet D, Longy M, et al. Germ-line mutation at BRCA1 affects the histoprognostic grade in hereditary breast-cancer. Cancer Res 1996;56:471-4.
66. Rubin SC, Benjamin I, Behbakht K, et al. Clinical and pathological features of ovarian-cancer in women with germ-line mutations of BRCA1. N Engl J Med 1996;335: 1413-6.
67. Jacquemier J, Eisinger F, Guinebretier JM, et al. Intraductal component and BRCA1-associated breast-cancer. Lancet 1996;348:1098
68. Sobol A, Stoppalyonnet D, BressacDePaillerets B, et al. Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res 1996;56:3216-9.
69. Stratton MR, Wooster R. Hereditary predisposition to breast-cancer. Curr Opin Genet Dev 1996;6:93-7.
70. Grade K, Hoffken K, Kath R, et al. BRCA1 mutations and phenotype. J Cancer Res Clin Oncol 1997;123:69-70.
71. Gowen LC, Johnson BL, Latour AM, et al. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 1996;12:191-4.
72. Boyd M, Harris F, Mcfarlane R, et al. A human BRCA1 gene knockout. Nature 1995;375:541-2.
73. Shinohara A, Ogawa H, Ogawa T. Rad51 protein involved in repair and recombination in saccharomyces-cerevisiae is a recA-like protein. Cell 1992;69:457-70.
74. Um DS, Hasty P. A mutation in mouse Rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol Cell Biol 1996;16:7133-43.
75. Tsuzuki T, Fujii Y, Sakumi K, et al. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci USA 1996;93:6236-40.
76. Monteiro ANA, August A, Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA 1996;93:13595-9.
77. Shao NS, Chai YL, Shyam E, et al. Induction of apoptosis by the tumor-suppressor protein BRCA1. Oncogene 1996; 13:1-7.
78. Futreal PA, Liu QY, Shattuckeidens D, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-2.
79. Merajver SD, Pham TM, Caduff RF, et al. Somatic mutations in the BRCA1 gene in sporadic ovarian-tumors. Nat Genet 1995;9:439-43.
80. Hosking L, Trowsdale J, Nicolai H, et al. A somatic BRCA1 mutation in an ovarian tumor. Nat Genet 1995;9:343-4.
81. Takahashi H, Behbakht K, Mcgovern PE, et al. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 1995;55:2998-3002.
82. Cletonjansen AM, Collins N, Lakhani SR, et al. Loss of heterozygosity in sporadic breast-tumors at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 1995;72:1241-4.
83. Cropp CS, Nevanlinna HA, Pyrhonen S, et al. Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res 1994;54:2548-51.
84. Futreal PA, Soderkvist P, Marks JR, et al. Detection of frequent allelic loss on proximal chromosome-17q in sporadic breast-carcinoma using microsatellite length polymorphisms. Cancer Res 1992;52:2624-7.
85. Hamann U, Herbold C, Costa S, et al. Allelic imbalance on chromosome 13q - evidence for the involvement of BRCA2 and RB1 in sporadic breast-cancer. Cancer Res 1996;56:1988-90.